Keyphrases
Systematic Meta-analysis
100%
Meta-analysis
72%
Major Depressive Disorder
57%
Randomized Clinical Trial
55%
Randomized Controlled Trial
33%
Clinical Analysis
31%
Treatment as Usual
29%
Depressive Symptoms
28%
Self-harm
27%
Cardiovascular Risk
27%
Cognitive Function
24%
After Surgery
24%
Patients with Depression
24%
Healthy Controls
24%
Patients with Schizophrenia
22%
Schizophrenia Spectrum Disorders
20%
Pancreatic Neuroendocrine Tumors (pNETs)
19%
Quality of Life
18%
Denmark
18%
Lifestyle Coaching
18%
Dopamine Agonist
18%
HPA Axis
18%
Transsphenoidal Surgery
18%
Care Coordination
18%
Suicide Attempt
17%
Exercise Effect
17%
Clinical Trials
16%
Placebo
16%
Depressed Patients
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Standardized Mean Difference
16%
Confidence Interval
16%
Abdominal Obesity
15%
Waist Circumference
15%
Remission
15%
Exercise Intervention
15%
Unipolar Depression
15%
Risk of Bias
14%
Physical Activity
14%
Severe Mental Illness
14%
Metabolic Variables
14%
Cortisol
13%
Embase
13%
Serious Adverse Events
13%
Clinical Depression
13%
Cardiovascular Mortality
13%
Suicidality
13%
Schizophrenia
12%
Small Intestinal Neuroendocrine Tumors
12%
Neuroendocrine Tumor
12%
Medicine and Dentistry
Systematic Review
43%
Meta-Analysis
40%
Randomized Clinical Trial
26%
Neuroendocrine Tumor
25%
Cardiovascular Disease
20%
Neoplasm
19%
Schizophrenia Spectrum Disorder
18%
Care Coordination
18%
Transsphenoidal Surgery
18%
Disease
17%
Abdominal Obesity
16%
Randomized Controlled Trial
15%
Major Depressive Episode
13%
Cardiovascular Risk
12%
Sequential Analysis
12%
Systematic Review with Meta-Analysis
12%
Automutilation
12%
Diagnosis
12%
Disease Specific Survival
12%
Dopamine Agonist
12%
Contralateral
12%
Hydrocortisone
12%
Primary Hyperaldosteronism
12%
Physical Activity
11%
Hypophysis Function
10%
Maturity Onset Diabetes of the Young
10%
Symptom
10%
Drug Therapy
10%
Retrospective Study
9%
Hemoglobin A1c
9%
Depression
9%
Chromogranin A
9%
Quality of Life
9%
Obesity
9%
Recurrence Free Survival
9%
Cardiorespiratory
8%
Negative Syndrome
8%
Smoking
8%
Adverse Event
8%
Population
8%
Combination Therapy
8%
Prolactinoma
8%
Treatment Effect
8%
Body Mass Index
7%
Cohort Analysis
7%
Meta-Regression
7%
Typical Antipsychotic
7%
Cardiovascular System
7%
Somatics
7%
Diabetes
7%
